AstraZeneca
oncology near term commercial performance drivers continuing launch execution expanding geographic presence establishing new soc demand expansion with dot moving soc with new launches strong start in rapid topaz uptake launch underway in lung leading in ovarian and launches underway increasing us lead in growing class extending dot positive for maleate tablet continued demand in her destiny breast launches accelerating a | AstraZeneca
Company
Deck Type
Sector
Industry
Deck date
February 2023
Slide
16 of 45
Related slides by other companies
Genetron
Results
June 2022
solid tumor development plan | Genetron
Other recent decks by AstraZeneca
See all presentations (27 decks)
Results
February 2024
Investor Conference
January 2024
Results
November 2023
Results
July 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io